Product Overview
Protect yourself and your loved ones this flu season with Flucelvax® Trivalent Influenza Virus Vaccine, specifically formulated for the 2024-2025 season. This trivalent inactivated vaccine contains 45 mcg of each of the three targeted influenza virus strains per 0.5 mL dose, providing comprehensive coverage against the most prevalent flu viruses expected this year.
Product Features
- Designed to protect against three strains of the influenza virus for the 2024-2025 season
- Formulated to induce an immune response to help prevent influenza
- Clinically studied with a favorable safety and tolerability profile
Product Specification
| Catalog Number/SKU | MF-70461055410 |
| Application | Flu Vaccine |
|---|---|
| Container Type | Multiple-Dose Vial |
| Dosage Form | Injection |
| Generic Drug Name | Influenza Virus Vaccine, Trivalent Inactivated |
| Storage Requirements | Requires Refrigeration |
| Strength | 45 mcg / 0.5 mL |
| Type | Intramuscular |
| User | Indicated for People 6 Months of Age and Older |
| Volume | 5 mL |
